Yes, he said we would have 5 more NASH patients through the open label 350 mg trial in "5 days or so". I'm going to give it a week and then add a few more days until they go through the data and then, hopefully, tell us.

If I understood him correctly, he said we were changing the interim look at Brazil critical covid trial to 50 patients. I think originally it was scheduled for 127 patients. That seems pretty drastic to me. Any of you biostatistically sophisticated posters have any idea how likely we can hit statsig with that small a number? TIA, Ganesha